X-108072755-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_182607.5(VSIG1):c.491C>T(p.Ala164Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,207,950 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_182607.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG1 | NM_182607.5 | c.491C>T | p.Ala164Val | missense_variant | 4/7 | ENST00000217957.10 | NP_872413.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG1 | ENST00000217957.10 | c.491C>T | p.Ala164Val | missense_variant | 4/7 | 1 | NM_182607.5 | ENSP00000217957.3 | ||
VSIG1 | ENST00000415430.7 | c.599C>T | p.Ala200Val | missense_variant | 5/8 | 2 | ENSP00000402219.3 | |||
VSIG1 | ENST00000485533.1 | n.327C>T | non_coding_transcript_exon_variant | 3/4 | 5 | |||||
VSIG1 | ENST00000479635.1 | n.-41C>T | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000361 AC: 4AN: 110852Hom.: 0 Cov.: 22 AF XY: 0.0000302 AC XY: 1AN XY: 33074
GnomAD3 exomes AF: 0.0000545 AC: 10AN: 183480Hom.: 0 AF XY: 0.0000589 AC XY: 4AN XY: 67914
GnomAD4 exome AF: 0.0000155 AC: 17AN: 1097098Hom.: 0 Cov.: 29 AF XY: 0.0000276 AC XY: 10AN XY: 362486
GnomAD4 genome AF: 0.0000361 AC: 4AN: 110852Hom.: 0 Cov.: 22 AF XY: 0.0000302 AC XY: 1AN XY: 33074
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at